Skip to Main Content

Paper Details

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies.
Pathog Immun
37
2022
COVID, Nirmatrelvir, SARS, SARS-CoV, SARS-CoV-2, nirmatrelvir, participant, participants
Author NameAffiliation
Jeffrey N MartinUniversity of California san francisco
Timothy J HenrichUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
  • 1 - 4

Datasets

Release 1.2